Phase 2 Studies of AGN-214868 for Post Herpetic Neuralgia and Overactive Bladder - ONA
Links shared publicly online about this topic.
- 468total visits
Phase 2 Studies of AGN-214868 for Post Herpetic Neuralgia and Overactive Bladder - ONA
Syntaxin, partnered with Allergan, announced the initiation of two Phase 2 studies of AGN-214868 for the treatment of patients with post herpetic neuralgia and overactive bladder.
View full resource at oncologynurseadvisor.com
Tags: Urinary System, Overactive Bladder, Phase 2 Clinical Trial, Allergan, Bladder Dysfunction
Most Recently Shared on March 2, 2011 at 5:06 pm By:
Phase 2 Studies of AGN-214868 for Post Herpetic Neuralgia and Overactive Bladder http://goo.gl/fb/Gqz5e
Phase 2 Studies of AGN-214868 for Post Herpetic Neuralgia and Overactive Bladder - MPR
empr.com — “Syntaxin, partnered with Allergan, announced the initiation of two Phase 2 studies of AGN-214868 for the treatment of patients with post herpetic neuralgia and overactive bladder.” View full resource at empr.com
Most Recently Shared on March 2, 2011 at 5:05 pm By:
MPR News: Phase 2 Studies of AGN-214868 for Post Herpetic Neuralgia and Overactive Bladder: Syntaxin, partnered ... http://bit.ly/gedzCz
Advertisement
